Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indrajit Ghosh

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Vaccine|August 27, 2025
Offering Hepatitis B vaccination to vulnerable populations: How can we plug the gaps?Maeve Barlow, Stuart Flanagan, Indrajit Ghosh, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2025
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practiceFlora Olcott, Philip D Oddie, Maeve J Barlow, et al.
Elife|February 9, 2023
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agendaEmily Martyn, Sarah Eisen, Nicky Longley, et al.
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
Journal of Virology|July 22, 2016
Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic MiceMarianna Di Scala, Itziar Otano, Irene Gil-Fariña, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2020
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?Lucy J Garvey, Graham S Cooke, Colette Smith, et al.
Wellcome Open Research|June 29, 2026
Viral hepatitis and liver disease in the Mongolian community in London ('MoLo'): A mixed methods study protocol to investigate the epidemiology and burden of disease to inform clinical and public health interventionsEmily Martyn, Nara Dashdorj, Jessica Carter, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Vaccine|August 27, 2025
Offering Hepatitis B vaccination to vulnerable populations: How can we plug the gaps?Maeve Barlow, Stuart Flanagan, Indrajit Ghosh, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2025
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practiceFlora Olcott, Philip D Oddie, Maeve J Barlow, et al.
Elife|February 9, 2023
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agendaEmily Martyn, Sarah Eisen, Nicky Longley, et al.
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
Journal of Virology|July 22, 2016
Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic MiceMarianna Di Scala, Itziar Otano, Irene Gil-Fariña, et al.
The Lancet. Gastroenterology & Hepatology|March 12, 2022
A call for advocacy and patient voice to eliminate hepatitis B virus infectionPhilippa C Matthews, Kathryn Jack, Su Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2020
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?Lucy J Garvey, Graham S Cooke, Colette Smith, et al.
Wellcome Open Research|June 29, 2026
Viral hepatitis and liver disease in the Mongolian community in London ('MoLo'): A mixed methods study protocol to investigate the epidemiology and burden of disease to inform clinical and public health interventionsEmily Martyn, Nara Dashdorj, Jessica Carter, et al.
Pageof 10